- Home
- VOYA vs RVMD Comparison
VOYA vs RVMD Comparison
Compare VOYA & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOYA
- RVMD
- Stock Information
- Founded
- VOYA 1975
- RVMD 2014
- Country
- VOYA United States
- RVMD United States
- Employees
- VOYA N/A
- RVMD N/A
- Industry
- VOYA Life Insurance
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VOYA Finance
- RVMD Health Care
- Exchange
- VOYA Nasdaq
- RVMD Nasdaq
- Market Cap
- VOYA 7.0B
- RVMD 7.5B
- IPO Year
- VOYA 2013
- RVMD 2020
- Fundamental
- Price
- VOYA $71.85
- RVMD $37.91
- Analyst Decision
- VOYA Buy
- RVMD Strong Buy
- Analyst Count
- VOYA 13
- RVMD 13
- Target Price
- VOYA $82.83
- RVMD $68.38
- AVG Volume (30 Days)
- VOYA 717.0K
- RVMD 3.0M
- Earning Date
- VOYA 08-05-2025
- RVMD 08-06-2025
- Dividend Yield
- VOYA 2.50%
- RVMD N/A
- EPS Growth
- VOYA N/A
- RVMD N/A
- EPS
- VOYA 5.32
- RVMD N/A
- Revenue
- VOYA $7,968,000,000.00
- RVMD N/A
- Revenue This Year
- VOYA N/A
- RVMD N/A
- Revenue Next Year
- VOYA $4.86
- RVMD $226.82
- P/E Ratio
- VOYA $13.51
- RVMD N/A
- Revenue Growth
- VOYA 5.34
- RVMD N/A
- 52 Week Low
- VOYA $52.43
- RVMD $29.17
- 52 Week High
- VOYA $84.30
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- VOYA 54.55
- RVMD 47.59
- Support Level
- VOYA $70.89
- RVMD $37.72
- Resistance Level
- VOYA $73.01
- RVMD $39.62
- Average True Range (ATR)
- VOYA 1.35
- RVMD 1.20
- MACD
- VOYA -0.27
- RVMD 0.02
- Stochastic Oscillator
- VOYA 44.56
- RVMD 47.23
About VOYA Voya Financial Inc.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Wealth Solutions, Investment Management, and Health Solutions The Wealth segment generates roughly half of the company's revenue.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.